Cyclic nucleotides as targets for drug design.
D000067956:Adenylyl Cyclase Inhibitors; D000262:Adenylyl Cyclases / Q000378:metabolism; D000818:Animals; D002460:Cell Line; D002626:Chemistry, Pharmaceutical; D000242:Cyclic AMP / Q000378:metabolism / Q000502:physiology*; D006152:Cyclic GMP / Q000378:metabolism / Q000502:physiology*; D005246:Feedback; D006162:Guanylate Cyclase / Q000378:metabolism; D006728:Hormones / Q000502:physiology; D006801:Humans; D007477:Ions; D007700:Kinetics; D009711:Nucleotides / Q000502:physiology; D010743:Phospholipids / Q000502:physiology; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism; D011453:Prostaglandins / Q000502:physiology; D011494:Protein Kinases / Q000378:metabolism
D000067956:Adenylyl Cyclase Inhibitors; D006728:Hormones; D007477:Ions; D009711:Nucleotides; D010743:Phospholipids; D011453:Prostaglandins; D000242:Cyclic AMP; D011494:Protein Kinases; D010727:Phosphoric Diester Hydrolases; D000262:Adenylyl Cyclases; D006162:Guanylate Cyclase; D006152:Cyclic GMP